Tower Research Capital LLC (Trc) Astrazeneca PLC Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Astrazeneca PLC stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 16,362 shares of AZN stock, worth $1.08 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

16,362

Previous 93,621 82.52%

Holding current value

$1.08 Million

Previous $7.3 Million 82.55%

% of portfolio

0.03%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $5.92 Million - $6.77 Million	-77,259 Reduced 82.52%	16,362 $1.27 Million
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $5.06 Million - $6.13 Million	75,793 Added 425.13%	93,621 $7.3 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $1.88 Million - $2.14 Million	-30,813 Reduced 63.35%	17,828 $1.21 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $2 Million - $2.23 Million	32,254 Added 196.83%	48,641 $3.28 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $1.7 Million - $1.88 Million	-26,151 Reduced 61.48%	16,387 $1.11 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $2.61 Million - $2.83 Million	37,281 Added 709.17%	42,538 $3.04 Million
Q1 2023 May 09, 2023	SELL	$63.15 - $71.6 $32,964 - $37,375	-522 Reduced 9.03%	5,257 $365,000
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $4.35 Million - $5.66 Million	-80,291 Reduced 93.29%	5,779 $392,000
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $1.34 Million - $3.43 Million	25,301 Added 41.63%	86,070 $4.72 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $2.21 Million - $2.66 Million	-37,338 Reduced 38.06%	60,769 $4.02 Million
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $4.47 Million - $5.38 Million	80,190 Added 447.56%	98,107 $6.51 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $5,996 - $7,085	-111 Reduced 0.62%	17,917 $1.04 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $708,945 - $775,680	12,760 Added 242.22%	18,028 $1.08 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $777,964 - $966,912	-16,067 Reduced 75.31%	5,268 $316,000
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $49,848 - $57,543	1,057 Added 5.21%	21,335 $1.06 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $966,081 - $1.16 Million	19,911 Added 5425.34%	20,278 $1.01 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $8,172 - $9,409	154 Added 72.3%	367 $20,000
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $385,012 - $494,084	-8,933 Reduced 97.67%	213 $11,000
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $218,766 - $297,149	5,789 Added 172.45%	9,146 $408,000
Q4 2019 Feb 07, 2020	SELL	$42.46 - $50.46 $341,166 - $405,446	-8,035 Reduced 70.53%	3,357 $167,000
Q3 2019 Nov 05, 2019	SELL	$40.12 - $45.47 $268,242 - $304,012	-6,686 Reduced 36.98%	11,392 $508,000
Q2 2019 Aug 13, 2019	BUY	$37.28 - $41.68 $673,947 - $753,491	18,078 New	18,078 $746,000
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $496 - $602	-14 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $233,729 - $263,088	-6,341 Reduced 99.78%	14 $1,000
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $206,161 - $235,579	5,931 Added 1398.82%	6,355 $251,000
Q2 2018 Aug 15, 2018	BUY	$34.55 - $37.05 $14,649 - $15,709	424 New	424 $15,000
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $346,119 - $384,541	-10,498 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$32.09 - $34.78 $312,331 - $338,513	-9,733 Reduced 48.11%	10,498 $364,000
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $585,889 - $687,854	20,231	20,231 $685,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Astrazeneca PLC Transaction History